SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-003567
Filing Date
2010-01-19
Accepted
2010-01-19 18:21:02
Documents
1
Period of Report
2010-01-14

Document Format Files

Seq Description Document Type Size
1 WALKER 1-14-2010 rrd263085.html 4  
1 WALKER 1-14-2010 rrd263085.xml 4 3717
  Complete submission text file 0001181431-10-003567.txt   5588
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 126 ISABELLA AVE ATHERTON CA 94027
Business Address
WALKER JOHN PETER (Reporting) CIK: 0001213529 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 10534295